NEOSOR LTD

Executive Summary

NEOSOR LTD shows signs of a stable but fragile financial health typical of a micro-entity in early stages. The company maintains positive working capital and net assets, but very low absolute figures indicate limited liquidity and a thin equity buffer. Careful cash flow management and strategic growth initiatives are recommended to enhance financial resilience and support future expansion.

NEOSOR LTD - Analysis Report

Company Number: 13145306

Analysis Date: 2025-07-29 20:52 UTC

Financial Health Assessment for NEOSOR LTD

---

1. Financial Health Score: C

Explanation:
NEOSOR LTD demonstrates modest financial stability typical of a micro-entity in its early years of operation. The company shows positive net current assets and net assets in the most recent years, which is a healthy sign. However, the very low absolute values and a declining trend in current assets suggest limited operational scale and possible liquidity constraints. The absence of current liabilities in 2024 is positive, but the small size of net assets indicates the company is in a fragile state, requiring careful management to avoid distress.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Current Assets	£584	Very low cash and short-term asset base; indicates limited liquidity to cover short-term needs.
Current Liabilities	£0	No short-term debts due; a positive sign indicating no immediate financial obligations.
Net Current Assets (Working Capital)	£584	Positive but minimal working capital; company can cover short-term liabilities comfortably.
Net Assets (Shareholders’ Funds)	£584	Positive net worth but very small; equity base is thin, reflecting early-stage or small scale.
Share Capital	£1.00	Nominal share capital, typical of start-ups or micro-entities.
Employee Count	1	Very small workforce, indicating a micro-scale operation.

---

3. Diagnosis

NEOSOR LTD’s financial profile shows symptoms of a micro-scale business with limited operational breadth, typical for a newly incorporated company (since 2021). The balance sheet reveals a healthy cash flow "pulse" in that current assets exceed current liabilities and there are no immediate debts. However, the "vital signs" indicate fragility: the company’s asset base has contracted significantly from £2,429 in current assets in 2023 to just £584 in 2024, suggesting either a reduction in receivables, stock, or cash reserves.

The company’s net assets remain positive but very small, indicating a thin equity cushion that could be at risk if the company faces unexpected expenses or downturns. The absence of current liabilities in 2024 is encouraging but may also reflect limited borrowing or trade credit usage, which could limit operational flexibility.

The small workforce and micro-entity status mean the company is likely operating with minimal overhead and simple operations, reducing fixed costs but also limiting growth capacity.

---

4. Recommendations

1. Enhance Liquidity Management:

   • Maintain or increase current assets, especially cash and receivables, to ensure the company can meet unexpected expenses without distress.
   • Monitor cash flow closely to avoid a "flatline" scenario where cash reserves become dangerously low.

2. Consider Building a Buffer:

   • Explore modest financing options or increased share capital to strengthen the equity base and support growth or operational shocks.
   • Avoid excessive reliance on trade credit or loans until a stable cash flow pattern is established.

3. Grow Revenue and Asset Base:

   • Focus on expanding sales and improving receivables collection to rebuild current assets and working capital.
   • Develop strategic partnerships or supplier agreements to optimize inventory and reduce cash tied up in stock.

4. Cost Control and Operational Efficiency:

   • With only one employee, ensure operational processes are efficient and scalable as business grows.
   • Keep overheads minimal but invest prudently in areas that drive revenue growth.

---